Detected on Monday 16 November, 14h00
Debate on access to new medicines and quality of care
An opinion piece argues that the quality of care should not be measured solely by access to new medicines, while the pharmaceutical industry calls for faster authorizations. The debate takes place during the examination of the Social Security Financing Bill (PLFSS) in Parliament.
In brief
Health event (severity: notable) nationwide, first detected on 16 November 2026 at 14:00. Reported by 1 source (1 article), last updated on 16 November 2026 at 14:00.
- Category
- Health
- Severity
- Notable
- Place
National
- Detected
- 16 Nov, 14h00
- Updated
- 16 Nov, 14h00
- Reference
- no.21789
1 article · 1 source · 1 bord sur 3 · outlets: left 1, centre 0, right 0
Angle comparison
A comparison is written as soon as the event is covered by at least two sides (left, centre, right).
Lire les sources · 1 article, 1 source
- 14h00Le MondeCentre-leftOpinion16 NovEn France, la qualité des soins ne saurait se mesurer à l’accès aux nouveaux médicaments
L’industrie pharmaceutique réclame des mises sur le marché plus rapides pour ses médicaments, arguant d’une perte de chance, non vérifiée, pour les Français. A l’heure où le projet de loi de financement de la Sécurité sociale est examiné au Parlement, les entreprises tentent de faire bouger les lignes en leur faveur.